A phase I trial of OMS-527
Phase of Trial: Phase I
Latest Information Update: 17 Jul 2018
At a glance
- Drugs OMS 527 (Primary)
- Indications Drug abuse; Obsessive-compulsive disorders
- Focus Adverse reactions
- 17 Jul 2018 Status changed from planning to recruiting, as reported in the Omeros Corporation media release.
- 17 Jul 2018 According to an Omeros Corporation media release, first cohort of subjects has been dosed in this clinical trial. Trial completion is expected in the first half of 2019.
- 27 Jun 2018 Planned initiation date changed from 1 Jan 2018 to 1 Aug 2018, according to an Omeros Corporation media release.